149 related articles for article (PubMed ID: 38863627)
1. Angiogenesis in nasopharyngeal carcinoma: insights, imaging, and therapeutic strategies.
Xia C; Zhao J; Huang Y; Miao H; Zhao F
Front Oncol; 2024; 14():1331064. PubMed ID: 38863627
[TBL] [Abstract][Full Text] [Related]
2. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.
Wang J; Liu Y; Zhang Y; Li X; Fang M; Qian D
Cancer Med; 2023 Jun; 12(11):12608-12621. PubMed ID: 37097161
[TBL] [Abstract][Full Text] [Related]
3. Induction of chemokine (C-C motif) ligand 5 by Epstein-Barr virus infection enhances tumor angiogenesis in nasopharyngeal carcinoma.
Ma W; Feng L; Zhang S; Zhang H; Zhang X; Qi X; Zhang Y; Feng Q; Xiang T; Zeng YX
Cancer Sci; 2018 May; 109(5):1710-1722. PubMed ID: 29569795
[TBL] [Abstract][Full Text] [Related]
4. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis.
Xu Z; Fang S; Zuo Y; Zhang Y; Cheng R; Wang Q; Yang Z; Cai W; Ma J; Yang X; Gao G
Cancer Sci; 2011 Oct; 102(10):1789-98. PubMed ID: 21707863
[TBL] [Abstract][Full Text] [Related]
5. Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.
Lin C; Lin K; Zhang B; Su Y; Guo Q; Lu T; Xu Y; Lin S; Zong J; Pan J
Oncologist; 2022 Apr; 27(4):e340-e349. PubMed ID: 35380720
[TBL] [Abstract][Full Text] [Related]
6. STIM1-regulated exosomal EBV-LMP1 empowers endothelial cells with an aggressive phenotype by activating the Akt/ERK pathway in nasopharyngeal carcinoma.
Deng Y; Liu X; Huang Y; Ye J; He Q; Luo Y; Chen Y; Li Q; Lin Y; Liang R; Li Y; Wei J; Zhang J
Cell Oncol (Dordr); 2023 Aug; 46(4):987-1000. PubMed ID: 36917356
[TBL] [Abstract][Full Text] [Related]
7. Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling.
Wu A; Luo N; Xu Y; Du N; Li L; Liu Q
Int J Biol Sci; 2022; 18(1):242-260. PubMed ID: 34975330
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts.
Lee PJ; Sui YH; Liu TT; Tsang NM; Huang CH; Lin TY; Chang KP; Liu SC
J Exp Clin Cancer Res; 2022 Aug; 41(1):254. PubMed ID: 35986369
[TBL] [Abstract][Full Text] [Related]
9. HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis.
Ouyang X; Li K; Wang J; Zhu W; Yi Q; Zhong J
Front Oncol; 2023; 13():1271080. PubMed ID: 38304037
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis.
You Y; Shan Y; Chen J; Yue H; You B; Shi S; Li X; Cao X
Cancer Sci; 2015 Dec; 106(12):1669-77. PubMed ID: 26362844
[TBL] [Abstract][Full Text] [Related]
11. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.
Yoshizaki T; Kondo S; Dochi H; Kobayashi E; Mizokami H; Komura S; Endo K
Microorganisms; 2023 Dec; 12(1):. PubMed ID: 38276183
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.
Siak PY; Heng WS; Teoh SSH; Lwin YY; Cheah SC
J Transl Med; 2023 Nov; 21(1):786. PubMed ID: 37932756
[TBL] [Abstract][Full Text] [Related]
14. Exosomal Delivery of AntagomiRs Targeting Viral and Cellular MicroRNAs Synergistically Inhibits Cancer Angiogenesis.
Wang J; Jiang Q; Faleti OD; Tsang CM; Zhao M; Wu G; Tsao SW; Fu M; Chen Y; Ding T; Chong T; Long Y; Yang X; Zhang Y; Cai Y; Li H; Peng M; Lyu X; Li X
Mol Ther Nucleic Acids; 2020 Aug; 22():153-165. PubMed ID: 32927364
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligases in nasopharyngeal carcinoma and implications for therapies.
Zhou Z; Zheng K; Zhou S; Yang Y; Chen J; Jin X
J Mol Med (Berl); 2023 Dec; 101(12):1543-1565. PubMed ID: 37796337
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of HAX-1 overexpression in nasopharyngeal carcinoma.
You B; Cao X; Shao X; Ni H; Shi S; Shan Y; Gu Z; You Y
Oncotarget; 2016 Mar; 7(11):12505-24. PubMed ID: 26871467
[TBL] [Abstract][Full Text] [Related]
17. The role of Epstein-Barr virus in nasopharyngeal carcinoma.
Su ZY; Siak PY; Leong CO; Cheah SC
Front Microbiol; 2023; 14():1116143. PubMed ID: 36846758
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.
Su ZY; Siak PY; Leong CO; Cheah SC
Front Oncol; 2022; 12():840467. PubMed ID: 35311066
[TBL] [Abstract][Full Text] [Related]
19. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
Deng YF; Zhou DN; Pan ZY; Yin P
Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
[TBL] [Abstract][Full Text] [Related]
20. FGF19 promotes nasopharyngeal carcinoma progression by inducing angiogenesis via inhibiting TRIM21-mediated ANXA2 ubiquitination.
Shi S; Zhang Q; Zhang K; Chen W; Xie H; Pan S; Xue Z; You B; Zhao J; You Y
Cell Oncol (Dordr); 2024 Feb; 47(1):283-301. PubMed ID: 37782406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
